Innovative Keynotes Announced for 15th DPHARM Conference in Philadelphia

Exciting Keynotes for the 15th Annual DPHARM Conference

The anticipation is building for the 15th annual DPHARM conference, focused on innovative strategies aimed at modernizing clinical research. Scheduled for September 16-17, 2025, at the Loews Philadelphia Hotel, the event is set to showcase a stellar lineup of keynote speakers with extensive experience in the pharmaceutical industry.

A Prominent Panel

The Conference Forum, the organizers behind DPHARM, has unveiled the first wave of keynotes, featuring high-profile figures like Kenneth C. Frazier, the retired Chairman and CEO of Merck & Co. Inc., and Scott Gottlieb, former Commissioner of the U.S. Food and Drug Administration. Their insights will delve into the complexities of conducting clinical trials during an era of rapid change.

Tracey Kimball, the DPHARM Conference Director, highlighted the importance of these keynotes, emphasizing how they were selected based on recommendations from Research and Development executives who are focused on innovating processes for the benefit of patients. According to Kimball, “We are at a real moment of inflection and change in our industry,” a sentiment echoed by Sean Lynch of Novartis, who is serving as an advisor for this year's DPHARM.

Keynote Highlights

1. Kenneth C. Frazier is set to address the audience on leading with integrity during challenging times. He will discuss the importance of nurturing a culture geared towards innovation, particularly in the face of adversity.
2. Scott Gottlieb will share his perspectives on the future of clinical research, emphasizing how geopolitical factors currently impact Research and Development initiatives.
3. Victoria Gray, a patient advocate and the first recipient of CRISPR gene therapy for sickle cell disease, will recount her transformative experience in a clinical trial, underscoring the personal impact of research breakthroughs.
4. Kenneth Getz, a Professor at Tufts University, will touch upon the complexity of clinical trial protocols and the necessary steps to alleviate burdens faced by patients and clinical sites.

A Platform for Change

The DPHARM event is curated with contributions from over 75 advisors, including pharmaceutical industry leaders and patient advocates, ensuring a comprehensive view of current trends and challenges in clinical research. With more than 200 distinguished speakers lined up, attendees can expect a rich exchange of ideas and strategies aimed at enhancing patient care and improving clinical trial experiences.

Moreover, in addition to keynotes, DPHARM will also feature crucial discussions like the Partnerships with Sites summit, alongside the 10th annual CRAACO Clinical Research as a Care Option conference on September 15, 2025.

Conclusion

DPHARM represents a critical platform for industry professionals looking to stay ahead of the curve in clinical operations and research methodologies. With a strong focus on innovation, the conference promises invaluable insights into how the future of clinical trials will be shaped. To learn more about the DPHARM agenda and register for this pivotal event, visit DPHARM Conference.

For additional details about the event and registration, you can also explore the Conference Forum's site at [theconferenceforum.org].